Balance Sheet Data
AgeX Therapeutics, Inc. (AGE)
$0.64
+0.01 (+0.96%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 6.71 | 2.35 | 0.53 | 0.58 | 0.64 | 0.13 | 0.09 | 0.06 | 0.04 | 0.02 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 0.13 | 0.36 | 0.33 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
Account Receivables (%) | ||||||||||
Inventories | - | - | - | - | - | - | - | - | - | - |
Inventories (%) | ||||||||||
Accounts Payable | 1.16 | 1.32 | 1.66 | 0.12 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -1.89 | -0.64 | -1.61 | -0.12 | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 | -0 |
Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.